Mepenzolate bromide is an orally administered muscarinic receptor antagonist with Kis of 0.68 and 2.6 nM for hM2R and hM3R, respectively. Mepenzolate bromide is a GPR109A inhibitor. Mepenzolate is a post-ganglionic parasympathetic inhibitor, it decreases gastric acid and pepsin secretion and suppresses spontaneous contractions of the colon.
Molecular Weight:
420.34
Purity:
>99.0%
CAS Number:
[76-90-4]
Formula:
C21H26BrNO3
Target:
AChR/AChE
* VAT and and shipping costs not included. Errors and price changes excepted